Effect of Topical Microencapsulated Benzoyl Peroxide on the Skin Microbiome in Rosacea: A Randomized, Double-Blind, Crossover, Vehicle-Controlled Clinical Trial.
E-BPO shifted the skin microbiome in rosacea and demonstrated improvements in clinical symptoms and skin physical properties and a well-tolerated safety profile. US National Library of Medicine; Trial ID: NCT05675501]; URL: clinicaltrials.gov.
Authors
- Ofra Levy-Hacham
- Jeremy Sugarman (ORCID: https://orcid.org/0000-0001-7022-8332)
- Richard L. Gallo (ORCID: https://orcid.org/0000-0002-1401-7861)
- Jean Philippe York
- Dawnica Nadora
- Raja K. Sivamani (ORCID: https://orcid.org/0000-0001-7205-8162)
- Yvonne Nong (ORCID: https://orcid.org/0000-0001-8671-5573)
- Rinat Mizrahi
- Aidan Galati
Institutions
- University of California, San Francisco (US)
- Pacific Research Institute (US)
- University of California San Diego (US)
- Northern California Research (US)
- Galderma (United States) (US)
- Sol-Gel Technologies (Israel) (IL)
- Integrative Medicine Institute (US)
Publication Details
- Journal
- PubMed
- Published
- 2024-08-01
- Citations
- 4
- Primary Topic
- Acne and Rosacea Treatments and Effects
- Type
- article
- Field-Weighted Citation Impact
- 2.14
Funders
- Galderma